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The subgroup C human adenovirus L4 33-kDa protein is a nuclear phosphoprotein that plays a direct, but dispensable, role
in virion assembly. The r-strand open reading frame (ORF) for this protein lies opposite to the 59 end of the l-strand E2 early
(E2E) transcription units. To facilitate studies of regulation of E2E transcription, we wished to construct a mutant virus in
which the 33-kDa ORF was truncated to serve as a background into which specific E2E mutations could be introduced without
also altering the 33-kDa protein. We constructed viral DNA (vDNA) containing within the 33-kDa ORF two tandem, premature
stop codons that should prevent translation of the C-terminal 47 amino acids of the protein (D47). We report here the
unanticipated lethality of such truncation of the L4 33-kDa protein. Viral DNA harboring the D47 mutations did not produce
infectious virus when transfected into cultured cells. In contrast, infectious virus was recovered upon transfection of
revertant vDNA, indicating that the D47 mutations were responsible for the observed phenotype. The D47 mutations did not
affect E2E transcription or production of the E2 DNA-binding protein. Transfected D47 vDNA was replicated and directed the
production of early and late viral proteins, including hexon protein in the trimer conformation. However, no virus particles of
any kind were produced. We propose that truncation of the adenovirus 33-kDa protein results in a lethal, late block in the
infectious cycle during the assembly of progeny virions and discuss the implications of this phenotype for the mechanism
of virion assembly. © 2001 Academic PressINTRODUCTION
The efficient reproduction of human adenovirus type 5
(Ad5) and other members of subgroup C depends on
transcriptional and posttranscriptional regulatory mech-
anisms that ensure that the biosynthetic systems of the
host cell produce large quantities of viral structural pro-
teins and DNA genomes for assembly of progeny virus
particles (Shenk, 1996). The majority of viral regulatory
proteins begin to be synthesized prior to the onset of
viral DNA synthesis in the infected cell. These immedi-
ate-early and early adenoviral proteins execute a wide
variety of tasks, including activation of transcription from
all early promoters, induction of selective export of viral
mRNAs from the nucleus during the late phase of infec-
tion, provision of countermeasures to host immune re-
sponses, reprogramming of the host cell cycle to inte-
grate viral DNA synthesis with entry of the infected cell
into S phase, and protection against untimely apoptosis
of the host cell (Flint, 1986; Jones, 1995; Nevins, 1992;
Shenk, 1996; White, 1995; Wold et al., 1999). Most viral
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388late proteins, which are made following the initiation of
viral DNA synthesis, are structural proteins of virus par-
ticles or their precursors, but several are nonstructural
proteins that facilitate formation of progeny virions.
Early genetic studies indicated that the L4 100-kDa
protein, which is abundant in infected cells, but absent
from virus particles, is required for formation of hexon
trimers. The 100-kDa protein binds to nascent hexon
monomers, but not to the trimeric structural units (Cepko
and Sharp, 1982, 1983; Oosterom-Dragon and Ginsberg,
1981), and therefore is considered an essential chaper-
one for hexon assembly, one of the initial reactions in
formation of virus particles (D’halluin, 1995). In addition,
the L4 100-kDa protein facilitates assembly indirectly, for
it is required for efficient initiation of translation of viral
late mRNAs (Hayes et al., 1990). A second product of the
major late (ML) transcription unit also participates at an
early step in virion assembly. At nonpermissive temper-
atures, a virus carrying a temperature-sensitive mutation
in the coding sequence for the L1 52/55-kDa phospho-
proteins accumulated particles termed light intermedi-
ates, which are associated with fragments of viral DNA
derived from the left end of the genome (Hasson et al.,
1989). This property, and the loss of the 50–100 copies of
the proteins in such particles as virions were formed
(Hasson et al., 1992), suggested that the L1 52/55-kDa
proteins are required for encapsidation of the viral ge-
nome or serve as a temporary scaffold during formation
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389TRUNCATION OF THE ADENOVIRUS L4 33-kDa PROTEINof the capsid. More recently, Imperiale and colleagues
have observed that noncomplementing cells infected by
a mutant virus null for production of the L1 52/55-kDa
proteins produce only empty capsids, with which no
associated viral DNA could be detected (Gustin and
Imperiale, 1998). Thus, the primary function of the L1
52/55-kDa proteins appears to be in encapsidation of the
viral DNA genome. These proteins interact with a second
late protein, the IVa2 gene product, in yeast, in vitro and
in adenovirus-infected cells (Gustin et al., 1996). The
latter protein is the only known sequence-specific DNA-
binding protein encoded in the adenoviral genome (Tri-
bouley et al., 1994) and has been implicated (Lutz and
Kedinger, 1996; Tribouley et al., 1994) in the 20- to 30-fold
stimulation of transcription from the ML promoter char-
acteristic of the late phase of infection (Leong et al.,
1990; Mansour et al., 1986; Shaw and Ziff, 1980). How-
ever, the IVa2 protein was reported over 20 years ago to
be associated with putative assembly intermediates, but,
like the L1 52/55-kDa proteins to which it binds, much
reduced in concentration in, or absent from, virions (Pers-
son et al., 1979). The notion that the IVa2 protein is also
important for assembly of virus particles has received
strong support from the recent observation (Zhang and
Imperiale, 2000) that the protein binds specifically in vitro
to the packaging signal that directs encapsidation of viral
DNA (Hearing et al., 1987; Hearing and Shenk, 1983).
The L4 region of the Ad5 ML transcription unit in-
cludes the coding sequence for a fourth late, nonstruc-
tural protein, the 33-kDa protein (Oosterom-Dragon and
Anderson, 1983), originally discovered as a major phos-
FIG. 1. Organization of E2E transcription units and L4 33-kDa prote
genome is represented by the pair of solid horizontal lines, the r- and
indicating the site of initiation of E2E transcription by RNA polymeras
ranscription by both this enzyme (Shenk and Flint, 1991) and RNA poly
l., 1992) recognized by the latter enzyme (gray ovals) are shown to sc
ith the 59 splice site at the first exon–intron junction in E2E pre-mRN
-strand indicates the coding sequence for the C-terminal segment
runcated coding sequence present in the r-strand of the D47 mutant g
47 mutations (bp 26,941 to 26,963) is listed above, with the change
equence underlined is the complement of the t2 site of termination ophoprotein made in adenovirus-infected cells (Axelrod,
1978; Gambke and Deppert, 1981a; Russell and Blair,1977). Early studies established that this protein is local-
ized to infected cell nuclei (Axelrod, 1978; Cepko and
Sharp, 1982; Russell and Blair, 1977), but is not a com-
ponent of mature virions (Gambke and Deppert, 1981a,
b). Coding sequences for homologous proteins have
been identified in the genomes of other human serotypes
(Chroboczek et al., 1992; Davison et al., 1993; Slemenda
et al., 1990) and of ovine (Vrati et al., 1995), murine
(Cauthen and Spindler, 1996), and avian (Cao et al., 1998)
adenoviruses. Such conservation suggests that the L4
33-kDa protein fulfills an important function in the viral
life cycle, but the first clue about what that role might be
was obtained only very recently: introduction of a termi-
nation codon in place of that specifying residue 20 of the
L4 33-kDa protein of Ad5 reduced the yield of infectious
virus some sevenfold, as a result of defective assembly
(Fessler and Young, 1999). The sequence specifying the
C-terminus of this L4 protein in the r-strand contains in
the l-strand crucial sequences of the early promoter for
E2 transcription by RNA polymerase II and the RNA
polymerase III transcription unit and promoter that is
superimposed on the 59 end of the E2E RNA polymerase
II transcription unit (Fig. 1) (Ellsworth et al., 2001; Huang
et al., 1994; Pruzan et al., 1992). This arrangement se-
verely limits genetic analysis of the currently unknown
function of E2E RNA polymerase III transcription, as any
phenotypes induced by mutations designed to impair
transcription or alter the small RNAs made by this en-
zyme can be interpreted only if the changes do not alter
the L4 33-kDa protein coding sequence. In an effort to
circumvent this constraint, we introduced mutations de-
g sequences in opposite strands of the Ad5 genome. The viral DNA
ds, in the center of the figure, with the jointed arrow on the l-strand
e positions of the TATA sequence (gray square) required for efficient
e III (Pruzan et al., 1992) and the t1 and t2 termination sites (Pruzan et
e products of E2E transcription by the two enzymes are listed below,
rked by the vertical arrowhead. The pale gray arrow drawn above the
L4 33-kDa protein (Oosterom-Dragon and Anderson, 1983), with the
shown above. The wild-type sequence spanning the positions of the
ntroduce tandem stop codons indicated in the top line. The r-strand
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390 FINNEN, BIDDLE, AND FLINTrecombination in Escherichia coli and attempted to re-
cover the mutant virus. We report here the unanticipated
lethality of this alteration in the L4 33-kDa protein and
discuss the implications of the defects in virus particle
production induced by the mutations for mechanisms of
adenovirus assembly.
RESULTS
Considerations in designing the D47 mutations
The complex E2E transcriptional control region of sub-
group C human adenoviruses was the first demonstrated
to direct transcription in vivo by both RNA polymerase II
and RNA polymerase III (Huang et al., 1994). In an at-
tempt to create an appropriate background for genetic
analysis of the functional significance of this unusual
arrangement, we introduced into the L4 33-kDa protein
coding sequence two premature tandem stop codons
that should prevent synthesis of the C-terminal 47 amino
acids (D47; Fig. 1). Two stop codons were introduced to
minimize the possibility that revertant viruses would
arise during infection. The D47 mutations lie down-
stream of the E2E RNA polymerase III t2 termination site
at 190 and are also well removed from the internal
sequence of the RNA polymerase II and RNA polymerase
III promoters that we have recently defined (Ellsworth et
al., 2001), as well as from the first 59 splice site of RNA
polymerase II transcripts (Fig. 1).
The D47 mutations do not alter E2E transcription in vitro
To investigate whether the D47 mutations disrupted
some previously unrecognized l-strand transcriptional
control sequence, E2E transcription from wild-type and
D47 templates was compared in in vitro reactions spe-
FIG. 2. E2E transcription in vitro from wild-type and D47 templates.
Transcription of the templates by RNA polymerase II or III, primer
extension, and analysis and quantification of cDNAs synthesized from
E2E transcripts were as described under Materials and Methods. The
efficiency of transcription of the D47 template is expressed relative to
that of the wild type, set at 1.0. These values represent the means of
three independent experiments.cific for RNA polymerase II or RNA polymerase III. These
templates contained a mutation that eliminates the t1
termination site of the RNA polymerase III transcription
unit (Fig. 1), so that the latter enzyme synthesizes a
single transcript. This change facilitates quantitative
analyses, but does not alter the efficiency of transcription
(Ellsworth et al., 2001). Transcripts synthesized from the
wild-type and D47 templates by the two enzymes were
detected by primer extension and quantified as de-
scribed under Materials and Methods. As illustrated in
Fig. 2, the D47 mutations did not lead to major changes
in the efficiency of E2E transcription by either RNA poly-
merase II or RNA polymerase III (Fig. 2), giving us greater
confidence that they would not disrupt E2E transcription
in vivo.
The D47 mutant genome is unable to produce virus in
cultured human cells
One of the advantages of using a plasmid-based sys-
tem for introduction of mutations into viral genomes is
that the homologous recombination step that moves the
desired mutation(s) into viral DNA is carried out in bac-
teria. Thus, the presence of the mutation can be con-
firmed prior to introducing vDNA into permissive host
cells. Consequently, lethal mutations can be readily rec-
ognized as successful transfections that do not yield
infectious virus.
Attempts to recover D47 virus by transfecting 100-mm
dishes of 293 cells with 2 mg vDNA cleaved from
pTG3602/D47 were repeatedly unsuccessful. Cells trans-
fected with D47 vDNA did not exhibit an obvious cyto-
TABLE 1
Infectivity of Viral DNA in Cotransfections
DNAs
transfecteda
Days posttransfection to CPE
Final titerb
(PFU/ml)First detected Complete
WT2 4 7 6.4 3 108
WT1 4 7 3.3 3 108
D472 NDc ND 0
D471 8 10 1.3 3 108
a A 10-fold molar excess of an 1805-bp HindIII/BglII rescue fragment
ncompassing bp 26,328 to 28,133 of the Ad5 genome was included in
ransfections designated 1; a 10-fold molar excess of a 2314-bp PstI/
deI fragment derived from the plasmid pSP73 (Promega) was in-
luded in transfections designated 2.
b Final titers were determined after complete CPE was observed or
at 14 days posttransfection in the case of cells receiving D47 DNA
alone. Cells and medium were harvested together and subjected to five
freeze/thaw cycles. Cellular debris was removed by centrifugation and
the supernatants were titered in duplicate by plaque assay on 293
cells.
c CPE was not detectable (ND).pathic effect (CPE) (Table 1) and extracts prepared from
them failed to infect 293 cells. By contrast, 293 cells
391TRUNCATION OF THE ADENOVIRUS L4 33-kDa PROTEINtransfected with 2 mg wild-type vDNA cleaved from
pTG3602 included as a control in each experiment de-
veloped detectable and complete CPE by 3 to 4 days and
7 to 8 days, respectively, posttransfection and yielded
infectious virus (Table 1). Several approaches were
taken to eliminate technical problems as the reason for
the failure to recover the D47 mutant virus. The vDNA
preparations were routinely analyzed by gel electro-
phoresis to ensure that the quality and quantity of D47
and wild-type vDNAs were comparable. Transfection ef-
ficiency was monitored by inclusion of a plasmid direct-
ing synthesis of the green fluorescent protein, pEGFP-N1
DNA (Clontech, Palo Alto, CA), in each transfection.
When the expression of this protein in wild-type and D47
transfections was compared at 24 h posttransfection, no
differences in transfection efficiencies (20 to 30%) were
apparent (data not shown). In addition, adenovirus early
protein synthesis was examined in transfected HeLa
cells by indirect immunofluorescence labeling with
monoclonal antibodies recognizing the E1A or the E1B
55-kDa proteins. Both early proteins were detected in the
nucleus of cells transfected with either wild-type or D47
FIG. 3. Mutant vDNA can direct the production of E1A and E1B
55-kDa proteins. HeLa cells were transfected with 0.5 mg wild-type or
D47 vDNA and labeled with monoclonal antibodies recognizing the
proteins indicated and fluorescein isothiocyanate-conjugated second-
ary antibody, as described under Materials and Methods. Representa-
tive fields are shown.vDNA by 48 h posttransfection (Fig. 3). This result dem-
onstrated directly that the efficiency of transfection ofvDNA was similar for the wild-type and D47 genomes
and also indicated that early protein production is not
affected by the D47 mutations.
To determine whether the mutant genome harbored
any other defect(s) that would impair virus growth, a
revertant virus (D47rev2) was isolated by cotransfecting
a DNA fragment containing the wild-type sequence
spanning the D47 mutations with D47 vDNA (Table 1).
This revertant virus exhibited wild-type growth charac-
teristics (Fig. 4) and plaque morphology similar to that of
the wild type (data not shown). Revertant vDNA was also
constructed by rescuing SpeI-cut pTG3602/D47 with a
DNA fragment containing the wild-type sequence. Rever-
tant vDNA was as infectious as wild-type vDNA in trans-
fection experiments (Table 2) and the virus recovered
(D47rev1) also exhibited wild-type growth characteristics
(Fig. 4). Thus, the inability of D47 vDNA to yield infectious
virus in transfections can be attributed to the introduced
mutations.
Early and late viral proteins are produced from
transfected D47 vDNA
The results described in the previous section indicate
that D47 vDNA was able to direct the production of
adenovirus early E1A and E1B 55-kDa proteins with
kinetics and efficiency similar to those observed in cells
transfected with wild-type vDNA. In an effort to determine
the point at which the viral life cycle was blocked by
FIG. 4. Single-step growth curves of wild-type and D47 revertant
viruses. Confluent 60-mm dishes of 293 cells were infected at a mul-
tiplicity of infection of 10. At various times postinfection, cells and
medium were harvested together, and virus was released and quanti-
fied as described in the footnotes to Table 1.
392 FINNEN, BIDDLE, AND FLINTthese mutations, we examined the production of other
viral proteins by indirect immunofluorescence micros-
copy. 293 cells were transfected with wild-type or D47
vDNA and labeled with monoclonal antibodies recogniz-
ing the E2 72-kDa DNA-binding protein (DBP), the L4
100-kDa protein, or the hexon protein in the trimer con-
firmation, and an FITC-conjugated secondary antibody.
The number of cells stained for each protein per field
was similar in cells transfected with wild-type and D47
TABLE 2
Titers of Virus Recovered from Varying Quantities
of Transfected Viral DNA
vDNA
transfected
Quantity
(mg)
Titera
(PFU/ml)
WT 2.0 2.1 3 108
10.0 3.7 3 108
D47 2.0 0
10.0 0
D47rev1 2.0 2.5 3 108
10.0 3.0 3 108
a Final titers were determined at 8 days posttransfection as de-
scribed in the footnotes to Table 1.
FIG. 5. Mutant vDNA can direct the production of the E2E 72-kDa an
vDNA and labeled using the monoclonal antibodies recognizing the prote
antibody, as described under Materials and Methods. Representative fields avDNA at 48 h posttransfection (Fig. 5). The mRNA spec-
ifying the DBP is processed from primary transcripts
synthesized from the E2E RNA polymerase II promoter
(Shenk, 1996). The production of DBP in cells transfected
with D47 mutant vDNA therefore provides further reas-
surance that E2E transcription was not significantly al-
tered by the D47 mutations. The ability of D47 vDNA to
direct the synthesis of viral late proteins, including at
least one structural protein, indicated that the block to
virus replication occurred late in the infectious cycle.
The DBP-specific monoclonal antibodies used in
these assays (A1) recognize only the native, functional
form of the protein (Reich et al., 1983). In high multiplicity
infections of HeLa cells analyzed during the late phase of
infection, these antibodies detect native DBP as distinct
spots within the nucleus (Ornelles and Shenk, 1991;
Voelkerding and Klessig, 1986). Similar punctate nuclear
staining was observed in some cells transfected with
both wild-type and D47 vDNA (Fig. 5). However, diffuse
nuclear staining was also apparent in other cells that
received either wild-type or D47 DNA (Fig. 5). This dif-
ference in staining patterns within the populations of
cells making the DBP is most likely the result of asyn-
chronous initiation of infectious cycles when the viral
genome is introduced by transfection.
late proteins. 293 cells were transfected with 0.5 mg wild-type or D47d viral
ins indicated and fluorescein isothiocyanate-conjugated secondary
re shown.
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During productive adenovirus infection, phase-dense,
vesicular structures with which the punctate DBP de-
tected by indirect immunofluorescence coincides are
formed in the nucleus (Ornelles and Shenk, 1991; Reich
et al., 1983; Sugawara et al., 1977; Voelkerding and Kles-
sig, 1986). These structures also contain newly repli-
cated viral DNA (Martinez-Palomo et al., 1967; Martinez-
Palomo and Granboulan, 1967; Moyne et al., 1978; re-
viewed in Bridge and Pettersson, 1995). The punctate
nuclear staining pattern exhibited by the DBP-specific
monoclonal antibodies in cells transfected with D47
vDNA (Fig. 5) indicated that centers of viral replication
were established. To complement this observation, we
wished to examine D47 vDNA replication by a more
direct means. We therefore monitored viral replication
using sensitivity to the restriction endonuclease DpnI to
distinguish input vDNA made in E. coli (sensitive) from
replicated viral DNA (resistant) (Hay, 1985). Low-molec-
ular-weight DNA was isolated from 293 cells transfected
with either wild-type or D47 vDNA by a modified Hirt lysis
procedure (see Materials and Methods) and analyzed by
Southern blotting following cleavage with KpnI or KpnI
and DpnI. In cells transfected by wild-type vDNA, DpnI-
resistant, replicated vDNA was routinely detected by 12 h
posttransfection (Fig. 6A). The fraction of such DpnI-
resistant DNA increased thereafter, with the concomitant
appearance of diffuse, low-mobility viral DNA (Fig. 6A)
that presumably represents replication intermediates
containing single-stranded DNA (Lechner and Kelly,
1977; Van Der Vliet, 1995). Similar results were obtained
with probes detecting L4 (Fig. 6) on E4 (data not shown)
FIG. 6. Replication of wild-type and D47 genomes transfected into 2
nd harvested at the times posttransfection listed at the top. Low-molec
y 2 and 1, respectively, at the top), and hybridized to a probe detect
aterials and Methods. The positions of the 2.95-kb KpnI fragment (bp
etected by the labeled L4 DNA are indicated by the arrows at the left.
ransfection, assayed exactly as in the experiment shown in A, is shoviral DNA sequences. In contrast, DpnI-resistant viral
DNA was not detected in cells transfected with D47vDNA until 24 h posttransfection and remained at lower
concentrations than wild-type vDNA-containing cells
throughout the period examined (Fig. 6B). This delay in
the onset of viral DNA synthesis and accumulation of
replicated DNA was observed in several independent
experiments in which wild-type DNA and D47 vDNA
were introduced into 293 cells in parallel. However, we
observed considerable variability in the fraction of DpnI-
resistant DNA appearing in the specific intervals post-
transfection examined in both wild-type and D47 trans-
fections (for example, compare the 48-h wild-type sam-
ples in Figs. 6A and 6B). It seems likely that such
variability is in large measure the result of the asyn-
chrony among infectious cycles established in individual
cells, when viral genomes are introduced by transfection
rather than by virus infection. A second parameter that
precluded quantitative comparison of the replication of
the wild-type and D47 genomes was the fact that infec-
tious virus, which can infect new host cells in the popu-
lation (also asynchronously), was produced following
transfection of the former but not the latter vDNA (Table
1). Despite these limitations, we can conclude that D47
vDNA can be replicated and that its replication is de-
layed compared to that of wild-type vDNA (Fig. 6).
Assembly of virus particles is defective in D47 vDNA-
transfected cells
The ability of the D47 genome to direct the production
of viral late proteins, including at least one structural
protein, and to be replicated, yet yield no infectious virus
prompted us to examine assembly of virus particles.
Cells were transfected with wild-type, D47, or revertant
. (A) Cells were transfected with 2.0 mg/100-mm dish wild-type vDNA
ight DNA was isolated, digested with KpnI or KpnI plus DpnI (indicated
NA sequences following transfer to membranes, as described under
to 28,787) and of the largest product of DpnI cleavage of this fragment
arison of the replication of wild-type (WT) and D47 vDNA by 48 h after
.93 cells
ular-we
ing L4 D
25,838vDNA and harvested at 5 days posttransfection. This
period was empirically determined to allow production of
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visual detection in CsCl density gradients, which were
used to separate virions from less dense empty particles.
Both types of particle were present in lysates of cells
transfected with either wild-type or D47rev1 vDNA, with
virions predominating (Fig. 7). In contrast, no particles
whatsoever could be seen in gradients to which lysates
of D47 vDNA-transfected cells were applied (Fig. 7).
Thus, the mutations introduced into the D47 genome
induced an apparently total block to assembly of virus
particles.
DISCUSSION
Truncation of the Ad5 L4 33-kDa protein 47 amino
acids before the C-terminus completely inhibited virus
replication (Tables 1 and 2). This lethal phenotype can be
attributed to the introduced mutations, for revertant vi-
ruses isolated by two different methods displayed wild-
type growth characteristics (Fig. 4) and D47 rev1 vDNA
directed the production of similar quantities of empty
capsids and virions as wild-type vDNA (Fig. 7). In design-
ing the D47 mutations, we avoided disrupting any known
splicing and transcriptional control signals, including the
recently described intragenic promoter sequences of the
l-strand E2E RNA polymerase II and RNA polymerase III
transcription units (Ellsworth et al., 2001). The results of
n vitro transcription assays (Fig. 2) as well as our ability
FIG. 7. Production of virus particles in cells transfected with wild-
type, D47, or revertant genomes. Crude lysates were prepared from
cells transfected with wild-type, D47, or D47 rev1 vDNA (left to right) and
virus particles separated by centrifugation through continuous CsCl
gradients as described under Materials and Methods. The total quan-
tity of infectious virus loaded onto each gradient, as determined by
duplicate plaque assays of the crude lysates, is given below each
gradient. The positions of empty capsids and virions are indicated at
the left.o detect the E2 72-kDa DBP in cells transfected with D47
DNA (Fig. 5) indicate that, as anticipated, E2E transcrip-ion was unaffected by these mutations. Nor did the D47
mutations interfere with production of the L4 100-kDa
protein, as its synthesis and assembly of hexon trimers,
which requires the 100-kDa protein (see Introduction),
were comparable in cells transfected with Ad5 and D47
vDNAs (Fig. 5).
Despite the block to production of infectious virus
particles (Tables 1 and 2), the D47 mutations did not
prevent synthesis of viral late proteins or formation of
intranuclear, E2 72-kDa DBP-containing structures with
the characteristic appearance of replication centers (Fig.
5). Accumulation of newly synthesized viral DNA was
delayed in D47 compared to Ad5 vDNA-transfected cells
(Fig. 6). However, this reduction in concentration of prog-
eny viral genomes was much less than that of virus
particles, which could not be detected by either biolog-
ical or physical assays (Tables 1 and 2, Fig. 7). These
properties therefore led us to conclude that truncation of
the L4 33-kDa protein resulted in a lethal failure in
assembly of progeny virions. The conclusion that the
33-kDa protein functions during adenovirus assembly is
consistent with a previous report that introduction of a
stop codon at position 20 in the coding sequence spe-
cifically impairs accumulation of viral particles, particu-
larly of those containing the viral genome (Fessler and
Young, 1999). In this study, the point in the assembly
pathway at which the L4 33-kDa protein acts could not
be identified. The results reported here establish that
this protein must participate very early in assembly, for
the D47 mutations blocked formation of all types of virus
particle (Fig. 7). Furthermore, the L4 33-kDa protein must
act earlier in the assembly pathway than the L1 52/55-
kDa proteins, for empty capsids are still formed in cells
infected by a mutant virus null for production of this L1
protein (Gustin and Imperiale, 1998).
The lethality associated with the D47 mutations was
surprising, as Fessler and Young (1999) observed that
elimination of synthesis of the L4 33-kDa protein in in-
fected cells reduced virus yield only some sevenfold.
One possible explanation for the much more severe
defect induced by the D47 mutations is that the truncated
33-kDa protein lacking the C-terminal 47 residues repre-
sents a dominant, negative form. Although cotransfection
of wild-type and D47 genomes yielded no clear evidence
for such dominance, the limitations of this approach
discussed previously make it difficult to exclude this
possibility. Alternatively, it may be that transient interac-
tions of the L4 33-kDa protein with one or more virion
components and/or with other nonstructural proteins
participating in assembly mediate the early assembly
function of this L4 protein, but are rendered irreversible
in the absence of the C-terminal portion of the protein. Be
that as it may, it is clear that the C-terminal segment of
the 33-kDa protein includes a crucial functional domain.
In this context, it is noteworthy that threepotential sites of
phosphorylation are removed in the truncated, D47 form
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395TRUNCATION OF THE ADENOVIRUS L4 33-kDa PROTEINof the protein. From a more general perspective, the
inability of this truncated form of the 33-kDa protein to
participate in productive assembly reaction is not unex-
pected. A central idea in macromolecular assembly is
that removal of C-terminal amino acids renders proteins
incompetent for proper assembly, providing a quality
control mechanism to minimize assembly errors that
could arise from the participation of N-terminal protein
fragments (Casjens, 1997). This hypothesis has been
experimentally verified in the case of viral structural
proteins (Garcea et al., 1987) as well as for viral scaf-
olding proteins (Casjens, 1997), one of the potential
oles proposed for the 33-kDa protein (Fessler and
oung, 1999).
Two general mechanisms of assembly of DNA-con-
aining virions can be distinguished by the criterion of
hether capsid assembly is coordinated with, or pre-
edes, genome encapsidation. During sequential as-
embly, a mechanism epitomized by double-stranded
NA bacteriophage, such as T4, l, and P22, a stable
apsid shell (the procapsid) is formed prior to entry of the
enome. In all such phage assembly pathways, scaffold-
ng proteins guide assembly of the procapsid and are
emoved early in packaging of the viral DNA (see
asjens and Hendrix, 1988; King and Chiu, 1997). Among
nimal viruses with DNA genomes, herpesviruses
learly assemble by this mechanism (see Steven and
pear, 1997). Adenoviruses have also been considered
o assemble in this way (see, for example, D’halluin,
995; Shenk, 1996). Such a sequential assembly model is
ased on several lines of evidence. These include the
roduction in infected cells of large quantities of empty
apsids that lack viral DNA and internal core proteins
Anderson et al., 1973; Ishibashi and Maizel, 1974; Maizel
t al., 1968; Oberg et al., 1975; Prage et al., 1972;
Sundquist et al., 1973); the presence in these particles of
several proteins absent from, or much reduced in con-
centration in, mature virions, including the L1 52/55-kDa
and IVa2 proteins (Evardsson et al., 1976; Hasson et al.,
1992; Ishibashi and Maizel, 1974; Persson et al., 1979;
Prage et al., 1972; Rosenwirth et al., 1974; Sundquist et
al., 1973; Winter and D’halluin, 1991); the detection of
small quantities of labile particles associated with viral
DNA fragments or the intact viral genome, termed light
and heavy intermediates, respectively (D’halluin et al.,
1978; Evardsson et al., 1976); and the partial chase of
label initially detected in light particles to heavy particles
and virions during pulse–chase labeling (D’halluin et al.,
1978; Evardsson et al., 1976). According to a sequential
assembly model, the failure of D47 vDNA-transfected
cells to accumulate detectable quantities of empty cap-
sids (Fig. 7) suggests that the L4 33-kDa protein func-
tions as a classical scaffolding protein, required for as-
sembly and/or stabilization of the capsid shell.This model for adenovirus assembly rests on the as-
sumption that extraction from infected cells and purifica-tion of the proposed precursor and intermediate particles
do not alter their composition or structure. The structure
designated the light intermediate cannot be a bona fide
intermediate in assembly of virions: as discussed above,
it lacks the complete genome. This particle may be
formed from a true intermediate in which the associating
DNA is susceptible to breakage, but the possibility that it
is the result of more substantial alterations has not been
excluded. In addition, experience in other viral systems
indicates that even stable, incomplete particles that ac-
cumulate to high concentrations such as empty capsids
are not necessarily precursors to virions. The 75S empty
capsid of poliovirus, initially considered a precursor into
which the viral RNA genome was inserted (Jacobson and
Baltimore, 1968), cannot associate with the viral genome
(Nugent and Kirkegaard, 1995) and forms in a cell-free
system for poliovirus replication only when the concen-
tration of viral RNA is low (Verlinden et al., 2000). Thus,
these structures are dead-end products or perhaps a
storage form of the 14S pentamers from which RNA-
containing provirions are assembled (see Verlinden et
al., 2000). Finally, a sequential mechanism of adenovirus
assembly predicts that deletion of the packaging signal,
which lies near the left end of the viral genome (Ham-
marsko¨ld and Winburg, 1980; Hearing et al., 1987; Hear-
ing and Shenk, 1983), would prevent formation of virions,
but have no effect on assembly of empty capsids. How-
ever, deletion of the packaging signal of Ad5 blocked
assembly of all virus particles, including empty capsids
(cited in Hasson et al., 1992; Hearing and Shenk, 1983),
indicating that assembly of the capsid shell must require
recognition of the DNA packaging signal by one or more
viral proteins. Thus, a mechanism of adenovirus assem-
bly in which capsid formation is coordinated with ge-
nome encapsidation appears plausible. The empty cap-
sids that accumulate during the Ad5 infectious cycle and
in the absence of the L1 52/55-kDa proteins would be
dead-end products, analogous to those formed in polio-
virus-infected cells (see above). In this case, the absence
of empty capsids in D47 vDNA-transfected cells would
implicate the L4 33-kDa protein in initiating coordination
of encapsidation of the genome with capsid formation,
perhaps by recruiting the L1 52/55-kDa and/or IVa2 pro-
teins believed to mediate encapsidation of viral DNA
(Gustin et al., 1996; Zhang and Imperiale, 2000).
MATERIALS AND METHODS
Cells and viruses
293 cells were used for routine propagation of viruses,
plaque assays, and transfections. The transfection effi-
ciency achieved in 293 cells was routinely 20–30%. Im-
munofluorescence assays for the E1A and E1B 55-kDa
proteins, which are made in 293 cells from integrated
viral DNA (Aiello et al., 1979), were carried out in HeLa
cells. Large-scale, high-titer viral stocks were prepared
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396 FINNEN, BIDDLE, AND FLINTfollowing low-multiplicity infection of HeLa cells in sus-
pension culture as described (Flint et al., 1975). Both 293
and HeLa cell monolayers were maintained in Dulbec-
co’s modified Eagle’s medium containing 10% calf serum;
HeLa cells in suspension were maintained in minimum
essential medium containing 5% calf serum. Transfection
of 293 or HeLa cells was carried out using the calcium
phosphate precipitation technique originally described
by Graham and Van der Eb (1973). The time posttrans-
fection is defined as the period elapsed following re-
placement of the medium after incubation of cells for a
sufficient period to allow uptake of the DNA precipitate
(usually overnight). Viral DNA introduced into human
cells was prepared by digestion of pTG3602-based plas-
mids (see next section) with PacI (Chartier et al., 1996).
Construction of the D47 mutant and D47 revertants
Two tandem stop codons that should prevent translation
f the C-terminal 47 amino acids of the L4 33-kDa protein
Fig. 1) were introduced by site-directed mutagenesis using
he pAlter system (Promega, Madison, WI) into a HindIII/
stI fragment comprising positions 26,328 to 27,684 in the
d5 genome. The entire HindIII/PstI fragment was se-
uenced to confirm the introduction of these D47 mutations
ut no additional alterations in the DNA sequence. The
utations were then introduced into the viral genome by
omologous recombination in E. coli using pTG3602, a
lasmid that contains the entire Ad5 genome bracketed by
acI sites, and the method described by Chartier et al.
1996). We took advantage of the unique SpeI site located
ithin the E2E transcription unit and used the HindIII/PstI
ragment containing the D47 mutations to rescue SpeI-
igested pTG3602. The introduction of the D47 mutations
nto pTG3602 (pTG3602/D47) was confirmed by sequenc-
ng a PCR product spanning the region of interest amplified
rom rescued pTG3602. The D47 revertant DNA was ob-
ained in a similar manner, using a wild-type HindIII/BglII
ragment encompassing bp 26,328 to 28,133 of the Ad5
enome to rescue SpeI-digested pTG3602/D47. The virus
ubsequently recovered from pTG3602/D47rev1 DNA is
eferred to as D47rev1. A second revertant virus (D47rev2)
as obtained by cotransfecting 293 cells with the wild-type
indIII/BglII fragment and D47 vDNA. The introduction of
he wild-type sequences was confirmed by sequencing
CR products spanning the region of interest amplified
rom pTG3602/D47rev1 or from viral DNA purified from
47rev2.
ndirect immunofluorescence assays
Cells used in indirect immunofluorescence assays
ere grown on 22-mm round glass coverslips (Fisher)
laced inside a well of a 6-well tissue culture dish. To
mprove the adherence of 293 cells in these assays, the
overslips were pretreated with 0.01% poly-L-lysine ac-
cording to the manufacturer’s instructions (Sigma, St.Louis, MO). vDNA (0.5 mg) was introduced into the cells
n each well as described above. At 48 h posttransfec-
ion, cells were fixed by incubation with 2 ml per well of
reshly prepared 4% paraformaldehyde in phosphate-
uffered saline (PBS) for 10 min at room temperature.
ixed cells were washed 3 times with PBS containing
.5% bovine serum albumin (PBS/BSA; 2 ml per well) and
ermeabilized for 3 min at room temperature with PBS
ontaining 0.1% Triton X-100 (1 ml per well). Fixed, per-
eabilized cells were washed 3 times with PBS/BSA and
ncubated overnight at 4°C with 1 ml of monoclonal
ybridoma supernatant diluted 1/100 in PBS/BSA. The
pecific monoclonal hybridoma supernatants used were
s follows: for E1A proteins, M73 (Harlow et al., 1985); for
he E1B 55-kDa protein, 2A6 (Sarnow et al., 1982); for the
E2E 72-kDa DNA-binding protein, A1 (Reich et al., 1983);
for the L4 100-kDa protein, 2-100K (Cepko et al., 1981;
Cepko and Sharp, 1983); and for hexon in the trimer
conformation, 2Hx-2 (Cepko and Sharp, 1982). Cells were
then washed 3 times with PBS/BSA, and 150 ml of the
secondary antibody, fluorescein isothiocyanate- (FITC-)
conjugated donkey anti-mouse IgG, prepared and di-
luted according to the manufacturer’s instructions (Jack-
son ImmunoResearch Laboratories, West Point, PA), was
applied directly to the coverslips. Cells were then incu-
bated for 60 min at 37°C in a humid chamber, washed 3
times with 2 ml of PBS, and mounted in PBS containing
50% (v/v) glycerol onto glass slides. Samples were ex-
amined using a Nikon epifluorescence microscope
equipped with a cooled CCD camera. Composites of
representative images were prepared using Adobe Pho-
toshop software.
In vitro transcription assays
RNA polymerase II- and RNA polymerase III-specific in
vitro E2E transcription in HeLa cell whole-cell (Leong
and Flint, 1984) and nuclear (Dignam et al., 1983) ex-
tracts, respectively, was analyzed under the conditions
described previously (Ellsworth et al., 2001). The wild-
type E2E template DNA (pHE2EDt1P) comprised posi-
tions 26,328 to 27,684 of the Ad5 genome with a mutation
that eliminates the first E2E RNA polymerase III termina-
tion signal, t1 (see Fig. 1), in the pAlter-1 vector. The
mutant template (pHE2EDt1P/D47) differed from wild
type only in C to T and G to T changes at bp 26,943 and
26,946, respectively (Fig. 1). E2E transcripts were de-
tected using an end-labeled oligonucleotide comple-
mentary to positions 165 to 185 of the transcription unit
in primer extension assays as described (Ellsworth et al.,
2001). The products of primer extension were separated
by electrophoresis in 6% denaturing polyacrylamide gels
(Kasai et al., 1992) and the signal corresponding to the
85-nucleotide E2E cDNA was quantified by PhosphorIm-
ager analysis (Molecular Dynamics).
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397TRUNCATION OF THE ADENOVIRUS L4 33-kDa PROTEINViral DNA replication analysis
Viral DNA was extracted from 100-mm dishes of 293
cells transfected with 2 or 2.5 mg of vDNA using a
modification of the Hirt cell lysis procedure (Hirt, 1967).
At various times posttransfection, cells were washed
with 5 ml of PBS and then incubated with 1 ml of 0.01 M
EDTA, pH 7.5, containing 0.6% (w/v) SDS for 20 min at
room temperature. Cell lysates were collected and incu-
bated for 8 h at 4°C following addition of NaCl to a final
concentration of 1 M. Lysates were then centrifuged at
12,000 rpm for 30 min at 4°C, and the supernatants were
diluted 1:5 with 0.01 M Tris–HCl, pH 7.5. Diluted super-
natants were incubated sequentially for 30 min at 37°C
with 20 mg/ml RNase and 1 mg/ml proteinase K and the
DNA was purified by two phenol/chloroform extractions
and two chloroform extractions. The DNA was precipi-
tated by the addition of 2.5 vol of ethanol and 5 mg/ml
tRNA carrier. DNA precipitates were collected and resus-
pended in 100 ml H2O, and portions of each sample were
digested with either KpnI or KpnI plus DpnI to distinguish
input DNA from replicated viral DNA. Digested DNAs
were electrophoresed through 0.6% agarose gels cast
and run in 0.45 M Tris–borate, pH 8.0, and transferred to
Zeta probe membranes (Bio-Rad) by alkaline capillary
transfer for 16 h according to the manufacturer’s instruc-
tions. Membranes were washed twice in 0.03 M sodium
citrate, pH 6.8, containing 0.3 M NaCl (23 SSC) and
prehybridized by incubation with 0.25 M Na2HPO4, pH
.2, containing 1 mM EDTA and 7% (w/v) SDS (Church
nd Gilbert, 1984) for 30 min at 65°C. They were then
ybridized in the same buffer with 32P-labeled, denatured
4 ORF 6 or L4 33-kDa coding sequence DNA for 16 h at
5°C. The viral DNAs were excised from plasmid vec-
ors, purified by gel electrophoresis, and labeled by ran-
om primed DNA synthesis using [a-32P]dCTP (300 Ci/
mmol New England Nuclear–Dupont) as described (Fein-
berg and Vogelstein, 1984). Membranes were washed 4
times for 20 min at 55°C in 13 SSC containing 0.5% (w/v)
SDS and exposed to Kodak XA/R film or to a Phospho-
rImager (Molecular Dynamics) screen.
Analysis of virion assembly
To prepare samples for examination of virus particles
by centrifugation to equilibrium in CsCl density gradi-
ents, ten 100-mm dishes of 293 cells were transfected
with 2 mg per dish vDNA, prepared as described above.
The cells were harvested at 5 days posttransfection,
washed twice with 10 ml of PBS, resuspended in 3 ml of
0.025 M Tris–HCl, pH 7.4, containing 0.15 M NaCl, 5 mM
KCl, 0.55 mM Na2HPO4, and 0.1% (w/v) dextrose, and
subjected to five freeze/thaw cycles. Cellular debris was
removed by centrifugation and 2.5 ml of each lysate was
3loaded onto a preformed 1.4 to 1.2 g/cm CsCl gradient.
portion of each lysate (400 ml) was retained for titration Dby plaque assay. Gradients were centrifuged at 35,000
rpm for 16 h at 4°C and photographed.
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